These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17235398)

  • 41. Predominance of a methicillin-resistant Staphylococcus aureus clone susceptible to erythromycin and several other non-beta-lactam antibiotics in a Greek hospital.
    Polyzou A; Slavakis A; Pournaras S; Maniatis AN; Sofianou D; Tsakris A
    J Antimicrob Chemother; 2001 Aug; 48(2):231-4. PubMed ID: 11481293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Methicillin-resistant Staphylococcus aureus--diagnosis and therapy].
    Wüllenweber J; Herrmann M
    HNO; 2003 Jun; 51(6):451-5. PubMed ID: 12835842
    [No Abstract]   [Full Text] [Related]  

  • 43. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.
    Sieradzki K; Roberts RB; Haber SW; Tomasz A
    N Engl J Med; 1999 Feb; 340(7):517-23. PubMed ID: 10021472
    [No Abstract]   [Full Text] [Related]  

  • 44. [MRSA--current aspects of resistance, pathology, epidemiology and therapy].
    Addicks JP; Götting M; Jensen AM; Quarcoo D; Wicker S; Uibel S; Groneberg DA
    Versicherungsmedizin; 2010 Dec; 62(4):183-8. PubMed ID: 21192484
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can beta-lactams be re-engineered to beat MRSA?
    Livermore DM
    Clin Microbiol Infect; 2006 Apr; 12 Suppl 2():11-6. PubMed ID: 16524423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital.
    Mallaval FO; Carricajo A; Delavenna F; Recule C; Fonsale N; Manquat G; Raffenot D; Rogeaux O; Aubert G; Tous J
    Clin Microbiol Infect; 2004 May; 10(5):459-61. PubMed ID: 15113326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [MRSA infection].
    Matsumoto K; Nagatake T; Takahashi A; Watanabe K
    Nihon Rinsho; 1993 Jan; 51 Suppl():884-92. PubMed ID: 8459625
    [No Abstract]   [Full Text] [Related]  

  • 48. Staphylococcus aureus as a paradigm of a persistent problem of bacterial multiple antibiotic resistance in Abha, Saudi Arabia.
    Bilal NE; Gedebou M
    East Mediterr Health J; 2000; 6(5-6):948-54. PubMed ID: 12197353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Micek ST
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two heterogeneously vancomycin-intermediate clinical isolates of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in a Turkish university hospital: brief report of a surveillance study.
    Torun MM; Bahar H; Demirci M; Altaş K; Bağdatli Y; Kocazeybek B; Kapi M; Hiramatsu K
    Int J Antimicrob Agents; 2005 Dec; 26(6):508-10. PubMed ID: 16256313
    [No Abstract]   [Full Text] [Related]  

  • 51. Evolving antimicrobial chemotherapy for Staphylococcus aureus infections: Our backs to the wall.
    Daum RS; Seal JB
    Crit Care Med; 2001 Apr; 29(4 Suppl):N92-6. PubMed ID: 11292882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The spectrum of antimicrobial resistance among methicillin resistant Staphylococcus aureus (MRSA) in a tertiary care centre in India.
    Pulimood TB; Lalitha MK; Jesudason MV; Pandian R; Selwyn J; John TJ
    Indian J Med Res; 1996 Apr; 103():212-5. PubMed ID: 8935741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. No mercy for MRSA: treatment alternatives to vancomycin and linezolid.
    Wegner DL
    MLO Med Lab Obs; 2005 Jan; 37(1):26-9. PubMed ID: 15743145
    [No Abstract]   [Full Text] [Related]  

  • 54. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The bacteria fight back.
    Taubes G
    Science; 2008 Jul; 321(5887):356-61. PubMed ID: 18635788
    [No Abstract]   [Full Text] [Related]  

  • 56. Nosocomial infection caused by methicillin-resistant Staphylococcus aureus in Palestine.
    Adwan K; Abu-Hasan N; Adwan G; Jarrar N; Abu-Shanab B; Abu-Zant A
    Microb Drug Resist; 2005; 11(1):75-7. PubMed ID: 15770099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibiotic susceptibility pattern of nosocomial isolates of staphylococcus aureus in a tertiary care hospital, Nepal.
    Shrestha B; Pokhrel BM; Mohapatra TM
    JNMA J Nepal Med Assoc; 2009; 48(175):234-8. PubMed ID: 20795464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
    Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML
    Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jul; 46(27):624-6. PubMed ID: 9218648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beta-lactam resistance: clinical implications for pediatric patients.
    Dajani AS
    J Int Med Res; 2002; 30 Suppl 1():2A-9A. PubMed ID: 11921492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.